We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its lead galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in prec... Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its lead galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.05 | -1.48367952522 | 3.37 | 3.55 | 2.88 | 211193 | 3.27164213 | CS |
4 | 0.94 | 39.4957983193 | 2.38 | 4.2684 | 2.26 | 314143 | 3.5469521 | CS |
12 | 1.61 | 94.1520467836 | 1.71 | 4.2684 | 1.59 | 156712 | 3.03408706 | CS |
26 | 1.25 | 60.38647343 | 2.07 | 4.2684 | 1.555 | 106249 | 2.6485841 | CS |
52 | 1.47 | 79.4594594595 | 1.85 | 4.2684 | 1.28 | 80945 | 2.31393648 | CS |
156 | -0.68 | -17 | 4 | 5.7 | 1.02 | 331984 | 3.22866064 | CS |
260 | -1.44 | -30.2521008403 | 4.76 | 5.7 | 1.02 | 399582 | 3.0300589 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions